» Articles » PMID: 31235033

Large No More: The Journey of Pulmonary Large Cell Carcinoma from Common to Rare Entity

Overview
Journal J Thorac Oncol
Publisher Elsevier
Date 2019 Jun 26
PMID 31235033
Citations 17
Authors
Affiliations
Soon will be listed here.
Citing Articles

Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.

Simbolo M, Centonze G, Gkountakos A, Monti V, Maisonneuve P, Golovco S Virchows Arch. 2024; 484(5):777-788.

PMID: 38168015 PMC: 11106141. DOI: 10.1007/s00428-023-03721-4.


LCMR1 Promotes Large-Cell Lung Cancer Proliferation and Metastasis by Downregulating HLA-Encoding Genes.

Liu L, Li C, Wu Z, Li Y, Yu H, Li T Cancers (Basel). 2023; 15(22).

PMID: 38001705 PMC: 10670470. DOI: 10.3390/cancers15225445.


Development and validation of a novel nomogram to predict the overall survival of patients with large cell lung cancer: A surveillance, epidemiology, and end results population-based study.

Zhou H, Gao P, Liu F, Shi L, Sun L, Zhang W Heliyon. 2023; 9(5):e15924.

PMID: 37223713 PMC: 10200837. DOI: 10.1016/j.heliyon.2023.e15924.


Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer.

Ortega M, Pekarek L, Navarro F, Fraile-Martinez O, Garcia-Montero C, Alvarez-Mon M J Pers Med. 2023; 13(2).

PMID: 36836402 PMC: 9959016. DOI: 10.3390/jpm13020167.


Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer.

Chhouri H, Alexandre D, Grumolato L Cancers (Basel). 2023; 15(2).

PMID: 36672453 PMC: 9856371. DOI: 10.3390/cancers15020504.